|
May 1
|
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
|
|
Mar 20
|
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
|
|
Dec 27
|
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
|
|
Dec 23
|
Beyond Air Independent Director Acquires 102% More Stock
|
|
Dec 21
|
Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
|
|
Nov 15
|
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
|
|
Aug 10
|
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024
|
|
Aug 8
|
2 ‘Strong Buy’ Penny Stocks That Could Rally All the Way to $10 (or More)
|
|
Aug 7
|
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)
|